IFNG and neoplasm: Moreover, this nanocarrier could also effectively revert the tumor’s immunosuppressive microenvironment, and increased antitumor immune responses by generating IL-10, increasing IFN-γ production, and inhibiting production of the immunosuppressive mediator TGF-β.